Patrick Walsh
Corporate Officer/Principal chez IMMUNIC, INC.
Profil
Patrick Walsh is currently the Chief Business Officer at Immunic, Inc. He previously worked as the Director of Business Development at Akebia Therapeutics, Inc. and as the Head of Corporate Development at AVEO Pharmaceuticals, Inc. Walsh received his undergraduate degree from Colby College and his graduate and Masters of Business Administration degrees from the University of Michigan.
Postes actifs de Patrick Walsh
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Corporate Officer/Principal | 14/10/2021 |
Anciens postes connus de Patrick Walsh
| Sociétés | Poste | Fin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Patrick Walsh
| Colby College | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
